SEC Form 4 · accession 0001457612-18-000070
GENOCEA BIOSCIENCES, INC. · GNCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Howard Mayer
Director
Period of report
Jun 21, 2018
Accepted (ET)
Jun 25, 2018 · 8:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001457612
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.99 | Jun 21, 2018 | A | 45,000 | A | Jun 21, 2019 | Jun 21, 2028 | Common Stock | 45,000 | 45,000 | D |
Explanation of responses
- F1The option vests 100% on the first anniversary of the grant date.